Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Sell
31
AHR Quote, Financials, Valuation and Earnings
Last price:
$30.44
Seasonality move
:
7.23%
Day range:
$29.40 - $30.00
52-week range:
$12.81 - $30.97
Dividend yield:
3.38%
P/E ratio:
--
P/S ratio:
1.87x
P/B ratio:
2.06x
Volume:
3.6M
Avg. volume:
1.9M
1-year change:
108.82%
Market cap:
$4.7B
Revenue:
$2.1B
EPS (TTM):
-$0.27
Analysts' Opinion
-
Consensus RatingAmerican Healthcare REIT has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $33.88, American Healthcare REIT has an estimated upside of 14.4% from its current price of $29.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $30.00 representing 100% downside risk from its current price of $29.61.
Fair Value
-
According to the consensus of 4 analysts, American Healthcare REIT has 14.4% upside to fair value with a price target of $33.88 per share.
AHR vs. S&P 500
-
Over the past 5 trading days, American Healthcare REIT has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
American Healthcare REIT does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
American Healthcare REIT has grown year-over-year revenues for 0 quarters straight. In the most recent quarter American Healthcare REIT reported revenues of $542.7M.
Earnings Growth
-
American Healthcare REIT has grown year-over-year earnings for 0 quarters straight. In the most recent quarter American Healthcare REIT reported earnings per share of -$0.21.
Enterprise value:
6.3B
EV / Invested capital:
1.58x
Price / LTM sales:
1.87x
EV / EBIT:
67.53x
EV / Revenue:
3.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
75.31x
Price / Operating cash flow:
45.97x
Enterprise value / EBITDA:
20.09x
Gross Profit (TTM):
$416.8M
Return On Assets:
-0.82%
Net Income Margin (TTM):
-1.83%
Return On Equity:
-1.84%
Return On Invested Capital:
-0.92%
Operating Margin:
7.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.9B | $2.1B | $482.6M | $542.7M | |
| Gross Profit | $336M | $356.8M | $416.8M | $97.5M | $112.2M | |
| Operating Income | $90.6M | $76.7M | $136.8M | $29.2M | $40.2M | |
| EBITDA | $233.8M | $324.3M | $315.5M | $62.2M | $55.4M | |
| Diluted EPS | -$1.23 | -$1.08 | -$0.27 | -$0.41 | -$0.21 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $269.2M | $297.1M | $354.9M | |
| Total Assets | -- | -- | $4.8B | $4.6B | $4.5B | |
| Current Liabilities | -- | -- | $1.5B | $1.5B | $946.9M | |
| Total Liabilities | -- | -- | $3.1B | $3.1B | $2.2B | |
| Total Equity | -- | -- | $1.6B | $1.5B | $2.3B | |
| Total Debt | -- | -- | $2.6B | $2.6B | $1.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $147.8M | $98.5M | $176.1M | $25.8M | $59.5M | |
| Cash From Investing | -$118.6M | $9.4M | -$8.7M | -$11.3M | $87.2M | |
| Cash From Financing | -$42.9M | -$129.1M | -$134.7M | -$5.9M | -$140M | |
| Free Cash Flow | $76.2M | -$1.3M | $84.1M | $364K | $29.8M | |
AHR
Sector
Market Cap
$4.7B
$1B
Price % of 52-Week High
95.62%
80.59%
Dividend Yield
3.38%
3.32%
Shareholder Yield
-26.77%
3.41%
1-Year Price Total Return
108.82%
-1.68%
Beta (5-Year)
--
0.886
Dividend yield:
3.38%
Annualized payout:
$0.00
Payout ratio:
-319.73%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$29.46
200-day SMA
Buy
Level
$23.73
Bollinger Bands (100)
Buy
Level
26.95 - 29.37
Chaikin Money Flow
Buy
Level
62.2M
20-day SMA
Buy
Level
$29.37
Relative Strength Index (RSI14)
Buy
Level
53.78
ADX Line
Buy
Level
10.36
Williams %R
Neutral
Level
-38.3648
50-day SMA
Buy
Level
$28.74
MACD (12, 26)
Buy
Level
0.27
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
116.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1466)
Sell
CA Score
(Annual)
Level (-0.7)
Buy
Beneish M-Score
(Annual)
Level (-2.4987)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (0.6905)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Stock Forecast FAQ
In the current month, AHR has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AHR average analyst price target in the past 3 months is $33.88.
-
Where Will American Healthcare REIT Stock Be In 1 Year?
According to analysts, the consensus estimate is that American Healthcare REIT share price will rise to $33.88 per share over the next 12 months.
-
What Do Analysts Say About American Healthcare REIT?
Analysts are divided on their view about American Healthcare REIT share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that American Healthcare REIT is a Sell and believe this share price will drop from its current level to $30.00.
-
What Is American Healthcare REIT's Price Target?
The price target for American Healthcare REIT over the next 1-year time period is forecast to be $33.88 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AHR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for American Healthcare REIT is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AHR?
You can purchase shares of American Healthcare REIT via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase American Healthcare REIT shares.
-
What Is The American Healthcare REIT Share Price Today?
American Healthcare REIT was last trading at $30.44 per share. This represents the most recent stock quote for American Healthcare REIT. Yesterday, American Healthcare REIT closed at $29.61 per share.
-
How To Buy American Healthcare REIT Stock Online?
In order to purchase American Healthcare REIT stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is down 28.36% over the past day.
Buy
54
TNXP alert for Mar 24
Tonix Pharmaceuticals Holding [TNXP] is up 32.39% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 4.67% over the past day.
